Minimum 10-year results of cementless total hip arthroplasty in patients with rheumatoid arthritis

References

• Clayton ML. Care of the rheumatoid hip. Clin Orthopaed Relat Res. 1973;90:70–6.
   PubMed Web of Science ®Google Scholar
• Eberhardt K, Fex E, Johnsson K, Geborek P. Hip involvement in early rheumatoid arthritis. Ann Rheum Dis. 1995;54(1):45–8.
   PubMed Web of Science ®Google Scholar
• Glick EN, Mason RM, Wenley WG. Rheumatoid arthritis affecting the hip joint. Ann Rheum Dis. 1963;22:416–23.
   PubMed Web of Science ®Google Scholar
• Lehtimaki MY, Kaarela K, Hamalainen MM. Incidence of hip involvement and need for total hip replacement in rheumatoid arthritis. An eight-year follow-up study. Scand J Rheumatol. 1986;15(4):387–91.
   PubMed Web of Science ®Google Scholar
• Ono K, Ohashi S, Oka H, Kadono Y, Yasui T, Omata Y, et al. The impact of joint disease on the Modified Health Assessment Questionnaire scores in rheumatoid arthritis patients: a cross-sectional study using the National Database of Rheumatic Diseases by iR-net in Japan. Modern Rheumatol. 2015;26(4):529–33.
   PubMed Web of Science ®Google Scholar
• Cracchiolo A, 3rd, Severt R, Moreland J. Uncemented total hip arthroplasty in rheumatoid arthritis diseases. A two- to six-year follow-up study. Clin Orthop Related Res. 1992;277:166–74.
   PubMed Web of Science ®Google Scholar
• Garcia Araujo C, Fernandez Gonzalez J Tonino A. Rheumatoid arthritis and hydroxyapatite-coated hip prostheses: five-year results. J Arthroplasty. 1998;13(6):660–7.
   PubMed Web of Science ®Google Scholar
• Keisu KS, Orozco F, McCallum JD, 3rd, Bissett G, Hozack WJ, Sharkey PF, et al. Cementless femoral fixation in the rheumatoid patient undergoing total hip arthroplasty: minimum 5-year results. J Arthroplasty. 2001;16(4):415–21.
   PubMed Web of Science ®Google Scholar
• Effenberger H, Ramsauer T, Bohm G, Hilzensauer G, Dorn U, and Lintner F. Successful hip arthroplasty using cementless titanium implants in rheumatoid arthritis. Arch Orthop Trauma Surg. 2002;122(2):80–7.
   PubMed Web of Science ®Google Scholar
• Dadoun S, Zeboulon-Ktorza N, Combescure C, Elhai M, Rozenberg S, Gossec L, et al. Mortality in rheumatoid arthritis over the last fifty years: systematic review and meta-analysis. Joint Bone Spine.2013;80(1):29–33.
   PubMed Web of Science ®Google Scholar
• Kauppi M, Sokka T, Hannonen P. Survey nonresponse is associated with increased mortality in patients with rheumatoid arthritis and in a community population. J Rheumatol. 2005;32(5):807–10.
   PubMed Web of Science ®Google Scholar
• Bjornadal L, Baecklund E, Yin L, Granath F, Klareskog L, Ekbom A. Decreasing mortality in patients with rheumatoid arthritis: results from a large population based cohort in Sweden, 1964–95. J Rheumatol. 2002;29(5):906–12.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, et al. The mortality of rheumatoid arthritis. Arthritis Rheum. 1994;37(4):481–94.
   PubMed Web of Science ®Google Scholar
• Abasolo L, Ivorra-Cortes J, Leon L, Jover JA, Fernandez-Gutierrez B, Rodriguez-Rodriguez L. Influence of demographic and clinical factors on the mortality rate of a rheumatoid arthritis cohort: a 20-year survival study. Semin Arthritis and Rheum. 2015;45(5):533–8.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Michaud K, Gefeller O, Choi HK. Predicting mortality in patients with rheumatoid arthritis. Arthritis Rheum. 2003;48(6):1530–42.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315–24.
   PubMed Web of Science ®Google Scholar
• Engh CA, Bobyn JD, Glassman AH. Porous-coated hip replacement. The factors governing bone ingrowth, stress shielding, and clinical results. J Bone Joint Surg Br. 1987;69(1):45–55.
   PubMedGoogle Scholar
• Engh CA, Hooten JP Jr, Zettl-Schaffer KF, Ghaffarpour M, McGovern TF, Macalino GE, et al. Porous-coated total hip replacement. Clin Orthopaed Rel Res. 1994;298:89–96.
   Google Scholar
• Eskelinen A, Paavolainen P, Helenius I, Pulkkinen P, Remes V. Total hip arthroplasty for rheumatoid arthritis in younger patients: 2,557 replacements in the Finnish Arthroplasty Register followed for 0-24 years. Acta Orthop. 2006;77(6):853–65.
   PubMed Web of Science ®Google Scholar
• Matsushita I, Morita Y, Ito Y, Motomura H, Kimura T. Long-term clinical and radiographic results of cementless total hip arthroplasty for patients with rheumatoid arthritis: minimal 10-year follow-up. Mod Rheumatol. 2014;24(2):281–4.
   PubMed Web of Science ®Google Scholar
• Tang WM, Chiu KY. Primary total hip arthroplasty in patients with rheumatoid arthritis. Int Orthopaed. 2001;25(1):13–16.
   PubMed Web of Science ®Google Scholar
• Nakashima Y, Sato T, Yamamoto T, Motomura G, Ohishi M, Hamai S, et al. Results at a minimum of 10 years of follow-up for AMS and PerFix HA-coated cementless total hip arthroplasty: impact of cross-linked polyethylene on implant longevity. J Orthopaed Sci. 2013;18(6):962–8.
   PubMed Web of Science ®Google Scholar
• Kurtz SM, Gawel HA, Patel JD. History and systematic review of wear and osteolysis outcomes for first-generation highly crosslinked polyethylene. Clin Orthopaed Rel Res. 2011;469(8):2262–77.
   PubMed Web of Science ®Google Scholar
• Hasegawa M, Sudo A, Hirata H, Uchida A. Ceramic acetabular liner fracture in total hip arthroplasty with a ceramic sandwich cup. J Arthroplasty. 2003;18(5):658–61.
   PubMed Web of Science ®Google Scholar
• Park YS, Hwang SK, Choy WS, Kim YS, Moon YW, Lim SJ. Ceramic failure after total hip arthroplasty with an alumina-on-alumina bearing. J Bone Joint Surg Am. 2006;88(4):780–7.
   PubMed Web of Science ®Google Scholar
• Hasegawa M, Sudo A. Ceramic failure; mecahnism and revision strategy (in Japanese). Seikeigeka·Saigaigeka. 2016;59(1):49–56.
   Google Scholar
• Broden C, Mukka S, Muren O, Eisler T, Boden H, Stark A, et al. High risk of early periprosthetic fractures after primary hip arthroplasty in elderly patients using a cemented, tapered, polished stem. Acta Orthopaed. 2015;86(2):169–74.
   PubMed Web of Science ®Google Scholar
• Lindahl H. Epidemiology of periprosthetic femur fracture around a total hip arthroplasty. Injury. 2007;38(6):651–4.
   PubMed Web of Science ®Google Scholar
• Schwarzkopf R, Oni JK, Marwin SE. Total hip arthroplasty periprosthetic femoral fractures: a review of classification and current treatment. Bull Hosp Jt Dis. 2013;71(1):68–78.
   Google Scholar
• Streit MR, Merle C, Clarius M, Aldinger PR. Late peri-prosthetic femoral fracture as a major mode of failure in uncemented primary hip replacement. J Bone Joint Surg Br. 2011;93(2):178–83.
   PubMed Web of Science ®Google Scholar
• Lindahl H, Malchau H, Herberts P, Garellick G. Periprosthetic femoral fractures classification and demographics of 1049 periprosthetic femoral fractures from the Swedish National Hip Arthroplasty Register. J Arthroplasty. 2005;20(7):857–65.
   PubMed Web of Science ®Google Scholar
• Colville J, Raunio P. Charnley low-friction arthroplasties of the hip in rheumatoid arthritis. A study of the complications and results of 378 arthroplasties. J Bone Joint Surg Br. 1978;60-B(4):498–503.
   PubMedGoogle Scholar
• Unger AS, Inglis AE, Ranawat CS, Johanson NA. Total hip arthroplasty in rheumatoid arthritis. J Arthroplasty. 1987;2(3):191–7.
   PubMedGoogle Scholar
• Ranawat CS, Peters LE, and Umlas ME. Fixation of the acetabular component. Clin Orthop Rel Res. 1997;(344:):207–15.
   PubMed Web of Science ®Google Scholar
• Conroy JL, Whitehouse SL, Graves SE, Pratt NL, Ryan P, Crawford RW. Risk factors for revision for early dislocation in total hip arthroplasty. J Arthroplasty 2008;23(6):867–72.
   PubMed Web of Science ®Google Scholar
• Itokawa T, Nakashima Y, Yamamoto T, Motomura G, Ohishi M, Hamai S, et al. Late dislocation is associated with recurrence after total hip arthroplasty. Int Orthop. 2013;37(8):1457–63.
   PubMed Web of Science ®Google Scholar
• Khatod M, Barber T, Paxton E, Namba R, Fithian D. An analysis of the risk of hip dislocation with a contemporary total joint registry. Clin Orthop Rel Res. 2006;447:19–23.
   PubMed Web of Science ®Google Scholar
• Jolles BM, Bogoch ER. Posterior versus lateral surgical approach for total hip arthroplasty in adults with osteoarthritis. Cochrane Database Syst Rev. 2004;1(1):Cd003828.
   Google Scholar
• Ravi B, Croxford R, Hollands S, Paterson JM, Bogoch E, Kreder H, et al. Increased risk of complications following total joint arthroplasty in patients with rheumatoid arthritis. Arthritis Rheumatol. 2014;66(2):254–63.
   PubMed Web of Science ®Google Scholar
• Ravi B, Escott B, Shah PS, Jenkinson R, Chahal J, Bogoch E, et al. A systematic review and meta-analysis comparing complications following total joint arthroplasty for rheumatoid arthritis versus for osteoarthritis. Arthritis Rheum. 2012;64(12):3839–49.
   PubMed Web of Science ®Google Scholar
• Creighton MG, Callaghan JJ, Olejniczak JP, Johnston RC. Total hip arthroplasty with cement in patients who have rheumatoid arthritis. A minimum ten-year follow-up study. J Bone Joint Surg Am. 1998;80(10):1439–46.
   PubMed Web of Science ®Google Scholar
• Fujishiro T, Hiranaka T, Hashimoto S, Hayashi S, Kurosaka M, Kanno T, et al. The effect of acetabular and femoral component version on dislocation in primary total hip arthroplasty. Int Orthop. 2015;40(4):697–702.
   PubMed Web of Science ®Google Scholar
• Roubille C, Richer V, Starnino T, McCourt C, McFarlane A, Fleming P, et al. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis. Ann Rheum Dis. 2015;74(3):480–9.
   PubMed Web of Science ®Google Scholar
• del Rincon I, Battafarano DF, Restrepo JF, Erikson JM, and Escalante A. Glucocorticoid dose thresholds associated with all-cause and cardiovascular mortality in rheumatoid arthritis. Arthritis Rheumatol. 2014;66(2):264–72.
   PubMed Web of Science ®Google Scholar
• Avina-Zubieta JA, Abrahamowicz M, De Vera MA, Choi HK, Sayre EC, Rahman MM, et al. Immediate and past cumulative effects of oral glucocorticoids on the risk of acute myocardial infarction in rheumatoid arthritis: a population-based study. Rheumatology (Oxford, England). 2013;52(1):68–75.
   PubMed Web of Science ®Google Scholar
• Solomon DH, Avorn J, Katz JN, Weinblatt ME, Setoguchi S, Levin R, et al. Immunosuppressive medications and hospitalization for cardiovascular events in patients with rheumatoid arthritis. Arthritis Rheum. 2006;54(12):3790–8.
   PubMed Web of Science ®Google Scholar
• Listing J, Kekow J, Manger B, Burmester GR, Pattloch D, Zink A, et al. Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFalpha inhibitors and rituximab. Ann Rheum Dis. 2015;74(2):415–21.
   PubMed Web of Science ®Google Scholar
• Sihvonen S, Korpela M, Mustonen J, Huhtala H, Karstila K, Pasternack A. Mortality in patients with rheumatoid arthritis treated with low-dose oral glucocorticoids. A population-based cohort study. J Rheumatol. 2006;33(9):1740–6.
   PubMed Web of Science ®Google Scholar
• Saag KG, Koehnke R, Caldwell JR, Brasington R, Burmeister LF, Zimmerman B, et al. Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events. Am J Med. 1994;96(2):115–23.
   PubMed Web of Science ®Google Scholar